Hospital Corp of China FY26 H1 net profit drops 74.5% to RMB 43 million; revenue slips 1.4% to RMB 732.77 million

• Hospital Corporation of China posted profit of RMB 42.96 million, down 74.5% from a year earlier.
• Revenue slipped 1.4% to RMB 732.77 million, reflecting an optimized general-hospital mix with lower pharmaceutical revenue.
• Operating profit rose to RMB 125.25 million; gross profit climbed to RMB 177.38 million.
• Adjusted net profit rose 43.2% to RMB 101.1 million; adjusted gross margin widened 4.4 percentage points to 25.3%.
• Second-half focus includes tighter risk controls, expansion tied to the silver economy, specialist alliances, and continued rollout of AI platforms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hospital Corporation of China Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260825-12298434), on August 25, 2026, and is solely responsible for the information contained therein.